admin

In this article VIACP DISCA 9888-HK 700-HK 8604.T-JP CSG.N-CH The warning by Japanese investment bank Nomura that it could incur billions of dollars in losses at a U.S. subsidiary was “pretty unfortunate,” an analyst said on Tuesday. Nomura on Monday flagged a potential $2 billion loss resulting from transactions with a client stateside. The bank’s
0 Comments
In this article WPF^ BFT^ NDAQ FNF BX London-based online payments company Paysafe is set to begin trading on U.S. public markets after merging with blank-check company Foley Trasimene Acquisition II Corp, billionaire business and sports executive Bill Foley told CNBC Monday. Foley, who set up the special purpose acquisition company, or SPAC, announced in December
0 Comments
Steven Heap/EyeEm/Getty Images The deadline to contribute to individual retirement accounts and health savings accounts is May 17, the same day that individual federal income tax returns are due, the IRS said Monday. The announcement comes after the agency postponed the filing deadline to May 17 from April 15 following increased calls for more time
0 Comments
Both sides agreed that generic statements about firms’ integrity and honesty can sometimes be the basis for securities fraud class-action suits. WASHINGTON — A frustrated Supreme Court heard arguments on Monday in a securities fraud class-action case against Goldman Sachs, with several justices indicating puzzlement about what they were meant to do in light of
0 Comments
In this article HAFAX Ronald Terry, 93, visiting his late-wife’s grave. He’s living with his daughter, Ellen Minor, who is his primary caregiver. Photo: Ellen Minor Over the past year, Ellen Minor has been caring for her 93-year-old father in their Covid bubble. It’s been far from easy. “I can’t tell you how close I
0 Comments
In this article AZN-GB The European Union could open up a “Pandora’s box” if it decides to restrict exports of coronavirus vaccines, a political analyst told CNBC last week. Vaccination drives in the 27-member bloc have been hindered by production issues. Anglo-Swedish firm AstraZeneca earlier this year cut its first-quarter target from 90 million doses
0 Comments